Terumo (OTCMKTS:TRUMY) Shares Gap Down – Time to Sell?

Terumo Corp. (OTCMKTS:TRUMY)’s stock price gapped down before the market opened on Thursday . The stock had previously closed at $13.09, but opened at $12.5101. Terumo shares last traded at $12.9315, with a volume of 916,960 shares changing hands.

Terumo Price Performance

The stock has a market capitalization of $19.17 billion, a P/E ratio of 21.66 and a beta of 0.75. The company has a current ratio of 2.51, a quick ratio of 1.46 and a debt-to-equity ratio of 0.07. The stock has a 50 day moving average of $14.65 and a 200-day moving average of $16.18.

Terumo (OTCMKTS:TRUMY) last posted its quarterly earnings results on Wednesday, November 12th. The company reported $0.16 EPS for the quarter, hitting analysts’ consensus estimates of $0.16. Terumo had a net margin of 12.35% and a return on equity of 9.39%. The firm had revenue of $1.86 billion for the quarter, compared to analysts’ expectations of $1.75 billion.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.